Long-term stability of endogenous B-type natriuretic peptide during storage at - 20 °C for later measurement with Biosite Triage assay

Clinical Biochemistry

Volumn 40, Issue 15, 2007, Pages 1104-1107

  Pereira, Marta ^a   Azevedo, Ana ^a   Severo, Milton ^a   Barros, Henrique ^a  

^a University of Porto   (Portugal)

Author keywords

B type natriuretic peptide; Immunoassay; Stability; Temperature

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EDETIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE TEST; KIDNEY FUNCTION; LONG TERM CARE; MALE; NORMAL HUMAN; PEPTIDE ANALYSIS; PORTUGAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHELF LIFE; STATISTICAL SIGNIFICANCE; STORAGE TEMPERATURE; TEMPERATURE MEASUREMENT;

AGED; AGED, 80 AND OVER; CRYOPRESERVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROTEIN DENATURATION; REAGENT KITS, DIAGNOSTIC; RESEARCH DESIGN; TIME FACTORS;

EID: 34548475334     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.06.014     Document Type: Article

References (20)

1. Munagala V.K., Burnett Jr. J.C., and Redfield M.M. The natriuretic peptides in cardiovascular medicine. Curr. Probl. Cardiol. 29 12 (2004) 707-769
2. Suttner S.W., and Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr. Opin. Crit. Care 10 5 (2004) 336-341
3. Bettencourt P.M. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 91 11 (2005) 1489-1494
4. Cheung B.M., and Brown M.J. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J. Hypertens. 12 4 (1994) 449-454
5. Buckley M.G., Markandu N.D., Miller M.A., Sagnella G.A., and MacGregor G.A. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J. Hum. Hypertens. 7 3 (1993) 245-250
6. Wang T.J., Larson M.G., Levy D., Leip E.P., Benjamin E.J., Wilson P.W., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am. J. Cardiol. 90 3 (2002) 254-258
7. Almeida P., Azevedo A., Rodrigues R., Dias P., Frioes F., Vazquez B., et al. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients. Rev. Port. Cardiol. 22 3 (2003) 327-336
8. Joffy S., and Rosner M.H. Natriuretic peptides in ESRD. Am. J. Kidney Dis. 46 1 (2005) 1-10
9. Azevedo A., Bettencourt P., Dias P., Abreu-Lima C., Hense H.-W., and Barros H. Population based study on the prevalence of the stages of heart failure. Heart 92 (2006) 1161-1163
10. Ramos E., Lopes C., and Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann. Epidemiol. 14 6 (2004) 437-441
11. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J. Am. Coll. Cardiol. 38 7 (2001) 2101-2113
12. Mueller T., Gegenhuber A., Dieplinger B., Poelz W., and Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin. Chem. Lab. Med. 42 8 (2004) 942-944
13. Yeo K.T., Wu A.H., Apple F.S., Kroll M.H., Christenson R.H., Lewandrowski K.B., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin. Chim. Acta 338 1-2 (2003) 107-115
14. Belenky A., Smith A., Zhang B., Lin S., Despres N., Wu A.H., et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin. Chim. Acta 340 1-2 (2004) 163-172
15. Gobinet-Georges A., Valli N., Filliatre H., Dubernet M.F., Dedeystere O., and Bordenave L. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin. Chem. Lab. Med. 38 6 (2000) 519-523
16. Gruson D., Rousseau M.F., de Coninck V., Ahn S.A., and Ketelslegers J.M. Influence of sampling and storage conditions on B-type natriuretic peptide immunoreactivity for 3 automated assays. Clin. Chem. 52 4 (2006) 766-767
17. Shimizu H., Aono K., Masuta K., Asada H., Misaki A., and Teraoka H. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin. Chim. Acta 285 1-2 (1999) 169-172
18. Shimizu H., Aono K., Masuta K., Asada H., Misaki A., and Teraoka H. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin. Chim. Acta 305 1-2 (2001) 181-186
19. Evans M.J., Livesey J.H., Ellis M.J., and Yandle T.G. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin. Biochem. 34 2 (2001) 107-112
20. Doust J.A., Glasziou P.P., Pietrzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch. Intern. Med. 164 18 (2004) 1978-1984